The delineation of the in vivo role of GATA-3 in human T cell differentiation is a critical step in the understanding of molecular mechanisms directing human immune responses. We examined T cell differentiation and T cell–mediated effector functions in individuals lacking one functional GATA-3 allele. CD4 T cells from GATA-3+/− individuals expressed significantly reduced levels of GATA-3, associated with markedly decreased T helper cell (Th)2 frequencies in vivo and in vitro. Moreover, Th2 cell–mediated effector functions, as assessed by serum levels of Th2-dependent immunoglobulins (Igs; IgG4, IgE), were dramatically decreased, whereas the Th1-dependent IgG1 was elevated compared with GATA-3+/+ controls. Concordant with these data, silencing of GATA-3 in GATA-3+/+ CD4 T cells with small interfering RNA significantly reduced Th2 cell differentiation. Moreover, GATA-3 mRNA levels increased under Th2-inducing conditions and decreased under Th1-inducing conditions. Taken together, the data strongly suggest that GATA-3 is an important transcription factor in regulating human Th2 cell differentiation in vivo.
Skip Nav Destination
Article navigation
2 February 2004
Brief Definitive Report|
February 02 2004
GATA-3 in Human T Cell Helper Type 2 Development
Alla Skapenko,
Alla Skapenko
1Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III
2Department of Internal Medicine III, University of Erlangen-Nuremberg, 91054 Erlangen, Germany
Search for other works by this author on:
Jan Leipe,
Jan Leipe
1Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III
2Department of Internal Medicine III, University of Erlangen-Nuremberg, 91054 Erlangen, Germany
Search for other works by this author on:
Uwe Niesner,
Uwe Niesner
3Deutsches Rheuma-Forschungszentrum, 10117 Berlin, Germany
Search for other works by this author on:
Koen Devriendt,
Koen Devriendt
4Department of Clinical Genetics, Centre for Human Genetics, University of Leuven, 3300 Leuven, Belgium
Search for other works by this author on:
Rolf Beetz,
Rolf Beetz
5University Children's Hospital, 55101 Mainz, Germany
Search for other works by this author on:
Andreas Radbruch,
Andreas Radbruch
3Deutsches Rheuma-Forschungszentrum, 10117 Berlin, Germany
Search for other works by this author on:
Joachim R. Kalden,
Joachim R. Kalden
2Department of Internal Medicine III, University of Erlangen-Nuremberg, 91054 Erlangen, Germany
Search for other works by this author on:
Peter E. Lipsky,
Peter E. Lipsky
6National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892
Search for other works by this author on:
Hendrik Schulze-Koops
Hendrik Schulze-Koops
1Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III
2Department of Internal Medicine III, University of Erlangen-Nuremberg, 91054 Erlangen, Germany
Search for other works by this author on:
Alla Skapenko
1Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III
2Department of Internal Medicine III, University of Erlangen-Nuremberg, 91054 Erlangen, Germany
Jan Leipe
1Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III
2Department of Internal Medicine III, University of Erlangen-Nuremberg, 91054 Erlangen, Germany
Uwe Niesner
3Deutsches Rheuma-Forschungszentrum, 10117 Berlin, Germany
Koen Devriendt
4Department of Clinical Genetics, Centre for Human Genetics, University of Leuven, 3300 Leuven, Belgium
Rolf Beetz
5University Children's Hospital, 55101 Mainz, Germany
Andreas Radbruch
3Deutsches Rheuma-Forschungszentrum, 10117 Berlin, Germany
Joachim R. Kalden
2Department of Internal Medicine III, University of Erlangen-Nuremberg, 91054 Erlangen, Germany
Peter E. Lipsky
6National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892
Hendrik Schulze-Koops
1Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III
2Department of Internal Medicine III, University of Erlangen-Nuremberg, 91054 Erlangen, Germany
Address correspondence to Hendrik Schulze-Koops, Nikolaus Fiebiger Center for Molecular Medicine, Clinical Research Group III, University of Erlangen-Nuremberg, Glueckstrasse 6, 91054 Erlangen, Germany. Phone: 49-9131-853-3795; Fax: 49-9131-853-4770; email: [email protected]
A. Skapenko and J. Leipe contributed equally to this work.
Received:
August 01 2003
Accepted:
December 01 2003
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 199 (3): 423–428.
Article history
Received:
August 01 2003
Accepted:
December 01 2003
Citation
Alla Skapenko, Jan Leipe, Uwe Niesner, Koen Devriendt, Rolf Beetz, Andreas Radbruch, Joachim R. Kalden, Peter E. Lipsky, Hendrik Schulze-Koops; GATA-3 in Human T Cell Helper Type 2 Development . J Exp Med 2 February 2004; 199 (3): 423–428. doi: https://doi.org/10.1084/jem.20031323
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement